Nature’s Sunshine Products, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION (Details)

OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended			9 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014 item	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2014
Segment information
Number of business segments									4us-gaap_NumberOfReportableSegments
Net sales revenue:
Total net sales revenue	$ 86,663us-gaap_SalesRevenueNet	$ 93,406us-gaap_SalesRevenueNet	$ 92,831us-gaap_SalesRevenueNet	$ 93,467us-gaap_SalesRevenueNet	$ 93,264us-gaap_SalesRevenueNet	$ 90,405us-gaap_SalesRevenueNet	$ 91,782us-gaap_SalesRevenueNet	$ 94,375us-gaap_SalesRevenueNet	$ 366,367us-gaap_SalesRevenueNet	$ 369,826us-gaap_SalesRevenueNet	$ 360,826us-gaap_SalesRevenueNet
Contribution margin:
Total contribution margin									138,975natr_ContributionMargin	141,966natr_ContributionMargin	138,582natr_ContributionMargin
Selling, general and administrative	30,634	30,200	29,941	29,152	33,020	27,773	28,068	29,522	119,927	118,383	104,716
Operating income	834us-gaap_OperatingIncomeLoss	5,546us-gaap_OperatingIncomeLoss	5,827us-gaap_OperatingIncomeLoss	6,841us-gaap_OperatingIncomeLoss	2,340us-gaap_OperatingIncomeLoss	6,512us-gaap_OperatingIncomeLoss	7,801us-gaap_OperatingIncomeLoss	6,930us-gaap_OperatingIncomeLoss	19,048us-gaap_OperatingIncomeLoss	23,583us-gaap_OperatingIncomeLoss	33,866us-gaap_OperatingIncomeLoss
Other income (expense)	349us-gaap_OtherNonoperatingIncomeExpense	(42)us-gaap_OtherNonoperatingIncomeExpense	(79)us-gaap_OtherNonoperatingIncomeExpense	(262)us-gaap_OtherNonoperatingIncomeExpense	249us-gaap_OtherNonoperatingIncomeExpense	(216)us-gaap_OtherNonoperatingIncomeExpense	1,522us-gaap_OtherNonoperatingIncomeExpense	438us-gaap_OtherNonoperatingIncomeExpense	(34)us-gaap_OtherNonoperatingIncomeExpense	1,993us-gaap_OtherNonoperatingIncomeExpense	1,573us-gaap_OtherNonoperatingIncomeExpense
Income from continuing operations before provision for income taxes	1,183	5,504	5,748	6,579	2,589	6,296	9,323	7,368	19,014	25,576	35,439
Capital expenditures:
Total capital expenditures									26,910	8,556	6,779
Depreciation and amortization:
Total depreciation and amortization									4,409	4,466	4,078
Assets:
Total Assets	196,799us-gaap_Assets				199,612us-gaap_Assets				196,799us-gaap_Assets	199,612us-gaap_Assets
Property, plant and equipment
Total property, plant and equipment	51,343us-gaap_PropertyPlantAndEquipmentNet				32,022us-gaap_PropertyPlantAndEquipmentNet				51,343us-gaap_PropertyPlantAndEquipmentNet	32,022us-gaap_PropertyPlantAndEquipmentNet
Impairment charge									2,947
Subsidiary in Venezuela
Property, plant and equipment
Total property, plant and equipment		0										0
Impairment charge												2,947
United States
Net sales revenue:
Total net sales revenue									148,219	152,209	154,716
Property, plant and equipment
Total property, plant and equipment	48,013				25,713				48,013	25,713
Other
Net sales revenue:
Total net sales revenue									163,834	183,410	178,104
Property, plant and equipment
Total property, plant and equipment	3,330				3,102				3,330	3,102
South Korea (Synergy)
Net sales revenue:
Total net sales revenue									54,314	34,207	28,006
Venezuela
Property, plant and equipment
Total property, plant and equipment					3,207					3,207
NSP Americas
Net sales revenue:
Total net sales revenue									184,625	195,924	199,794
Contribution margin:
Total contribution margin									75,673	80,095	80,324
Capital expenditures:
Total capital expenditures									25,581	8,018	5,684
Depreciation and amortization:
Total depreciation and amortization									3,438	3,568	3,339
Assets:
Total Assets	129,371				148,278				129,371	148,278
NSP Americas \| General health
Net sales revenue:
Total net sales revenue									79,022	82,332	87,280
NSP Americas \| Immune
Net sales revenue:
Total net sales revenue									23,881	24,013	24,410
NSP Americas \| Cardiovascular
Net sales revenue:
Total net sales revenue									12,665	13,268	13,483
NSP Americas \| Digestive
Net sales revenue:
Total net sales revenue									53,906	57,575	56,160
NSP Americas \| Personal care
Net sales revenue:
Total net sales revenue									4,025	5,214	5,792
NSP Americas \| Weight management
Net sales revenue:
Total net sales revenue									11,126	13,522	12,669
NSP Russia, Central and Eastern Europe
Net sales revenue:
Total net sales revenue									50,274	62,747	57,853
Contribution margin:
Total contribution margin									17,851	22,542	21,957
Capital expenditures:
Total capital expenditures									8	4	44
Depreciation and amortization:
Total depreciation and amortization									25	27	36
Assets:
Total Assets	6,679				11,233				6,679	11,233
NSP Russia, Central and Eastern Europe \| General health
Net sales revenue:
Total net sales revenue									18,841	22,690	20,540
NSP Russia, Central and Eastern Europe \| Immune
Net sales revenue:
Total net sales revenue									6,512	7,902	7,365
NSP Russia, Central and Eastern Europe \| Cardiovascular
Net sales revenue:
Total net sales revenue									3,104	4,324	4,367
NSP Russia, Central and Eastern Europe \| Digestive
Net sales revenue:
Total net sales revenue									13,171	15,693	14,501
NSP Russia, Central and Eastern Europe \| Personal care
Net sales revenue:
Total net sales revenue									6,073	8,817	8,908
NSP Russia, Central and Eastern Europe \| Weight management
Net sales revenue:
Total net sales revenue									2,573	3,321	2,172
Synergy WorldWide
Net sales revenue:
Total net sales revenue									128,101	108,290	100,670
Contribution margin:
Total contribution margin									43,888	38,011	36,142
Capital expenditures:
Total capital expenditures									1,321	534	1,051
Depreciation and amortization:
Total depreciation and amortization									946	871	703
Assets:
Total Assets	40,797				40,101				40,797	40,101
Synergy WorldWide \| General health
Net sales revenue:
Total net sales revenue									46,546	36,723	33,969
Synergy WorldWide \| Immune
Net sales revenue:
Total net sales revenue									974	1,394	1,104
Synergy WorldWide \| Cardiovascular
Net sales revenue:
Total net sales revenue									42,449	42,154	42,696
Synergy WorldWide \| Digestive
Net sales revenue:
Total net sales revenue									20,839	16,897	14,904
Synergy WorldWide \| Personal care
Net sales revenue:
Total net sales revenue									7,196	7,097	5,631
Synergy WorldWide \| Weight management
Net sales revenue:
Total net sales revenue									10,097	4,025	2,366
China and New Markets
Net sales revenue:
Total net sales revenue									3,367	2,865	2,509
Contribution margin:
Total contribution margin									1,563	1,318	159
Assets:
Total Assets	19,952								19,952
China and New Markets \| General health
Net sales revenue:
Total net sales revenue									1,566	1,306	1,180
China and New Markets \| Immune
Net sales revenue:
Total net sales revenue									445	367	319
China and New Markets \| Cardiovascular
Net sales revenue:
Total net sales revenue									235	211	188
China and New Markets \| Digestive
Net sales revenue:
Total net sales revenue									835	726	632
China and New Markets \| Personal care
Net sales revenue:
Total net sales revenue									83	74	70
China and New Markets \| Weight management
Net sales revenue:
Total net sales revenue									$ 203	$ 181	$ 120
Nature's Sunshine Products
Segment information
Number of business segments									2